Add to Cart View Cart/Checkout More Products

Volume 20, 2016 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2016 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 20 No. 1 January/February 2016 Volume 20, Number 1
Vol. 20 No. 2 March/April 2016 Volume 20, Number 2
Vol. 20 No. 3 May/June 2016 Volume 20, Number 3
Vol. 20 No. 4 July/August 2016 Volume 20, Number 4
Vol. 20 No. 5 September/October 2016 Volume 20, Number 5
Vol. 20 No. 6 November/December 2016 Volume 20, Number 6

Articles
Volume/IssuePageTitle
Vol. 20 No. 1 4 PreScription: Starting Year 20!
Vol. 20 No. 1 6 Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Vol. 20 No. 1 13 Microbial Identification in Pharmaceutical Compounding
Vol. 20 No. 1 20 Basic Principles of Lyophilization, Part 2
Vol. 20 No. 1 29 Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success
Vol. 20 No. 1 41 Formulation and Stability of Solutions
Vol. 20 No. 1 46 Calculations
Vol. 20 No. 1 48 Aprepitant 80-mg Capsules
Vol. 20 No. 1 49 Aripiprazole 10-mg Oral Dissolving Tablets
Vol. 20 No. 1 50 Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Vol. 20 No. 1 51 Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Vol. 20 No. 1 52 Mupirocin Calcium 2% Cream
Vol. 20 No. 1 53 Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Vol. 20 No. 1 54 Thrombin 1,000 Units/mL Topical Solution, Sterile
Vol. 20 No. 1 55 Tropicamide 1% Ophthalmic Solution
Vol. 20 No. 1 56 Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Vol. 20 No. 1 57 Voriconazole 10-mg/mL Ophthalmic Solution
Vol. 20 No. 1 58 Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Vol. 20 No. 1 63 Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Vol. 20 No. 1 71 A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Vol. 20 No. 1 81 Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Vol. 20 No. 1 86 PostScription: The Home Field Advantage
Vol. 20 No. 2 92 PreScription: Compounding: A Changing Paradigm
Vol. 20 No. 2 95 Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
Vol. 20 No. 2 99 Root Cause Analysis, Part 2: Sterile Compounding
Vol. 20 No. 2 107 Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Vol. 20 No. 2 114 Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives
Vol. 20 No. 2 125 Basics of Compounding: Capsules
Vol. 20 No. 2 137 Formulation and Stability of Solutions
Vol. 20 No. 2 142 Calculations
Vol. 20 No. 2 144 Blue Goo Anti-Itch Gel
Vol. 20 No. 2 145 Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Vol. 20 No. 2 146 Medicated Polyox Bandage for Skin Ulcers
Vol. 20 No. 2 147 Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Vol. 20 No. 2 148 Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Vol. 20 No. 2 155 Utilization of Compounded Medications in an Oral Medicine Practice
Vol. 20 No. 2 159 Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Vol. 20 No. 2 164 Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Vol. 20 No. 2 167 Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Vol. 20 No. 3 180 PreScription: Patient Access to Pharmaceuticals
Vol. 20 No. 3 182 Current Perspectives on the Syringe Delivery System
Vol. 20 No. 3 189 Compounding in Nigeria
Vol. 20 No. 3 194 IACP Names Voliva Executive Vice President
Vol. 20 No. 3 197 Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Vol. 20 No. 3 202 Does Your Drug Expertise Include Clinical Pharmaceutics?
Vol. 20 No. 3 209 Basics of Compounding: Special Capsules
Vol. 20 No. 3 217 Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Vol. 20 No. 3 224 Calculations
Vol. 20 No. 3 226 Carboplatin 50-mg/mL Injection
Vol. 20 No. 3 227 Cefotetan Disodium Injection
Vol. 20 No. 3 228 Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Vol. 20 No. 3 229 Dexpanthenol 5% Nasal Spray
Vol. 20 No. 3 230 Indomethacin Gel
Vol. 20 No. 3 231 Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Vol. 20 No. 3 232 Montelukast Sodium 5-mg Fast-Dissolving Film
Vol. 20 No. 3 233 Pain-Away II Headache Capsules
Vol. 20 No. 3 234 Sodium Nitroprusside 25-mg/mL Injection
Vol. 20 No. 3 235 Zolpidem Tartrate 5-mg and 10-mg Capsules
Vol. 20 No. 3 236 Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Vol. 20 No. 3 239 Topical Metered-dosing Dispenser Performance Evaluation
Vol. 20 No. 3 247 Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Vol. 20 No. 3 250 Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Vol. 20 No. 3 257 Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Vol. 20 No. 3 262 PostScription: Supporting Your Alma Mater: Whose World Will You Change?
Vol. 20 No. 4 268 PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Vol. 20 No. 4 271 Compounding Transdermal Medication for Feline Patients
Vol. 20 No. 4 277 Case Report: Pediatric Scar Management After Open-heart Surgery
Vol. 20 No. 4 283 Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Vol. 20 No. 4 294 IACP's 2016 Compounders on Capitol Hill Asks
Vol. 20 No. 4 298 Basics of Compounding: Compounding Films
Vol. 20 No. 4 307 Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Vol. 20 No. 4 316 Calculations
Vol. 20 No. 4 318 Dolasetron Mesylate 20-mg/mL Injection
Vol. 20 No. 4 319 Gatifloxacin 0.5% Ophthalmic Solution
Vol. 20 No. 4 320 Mebendazole 100-mg Capsules
Vol. 20 No. 4 321 Neomycin Sulfate 25-mg/mL Oral Solution
Vol. 20 No. 4 322 Nystatin 100,000-units Vaginal Inserts
Vol. 20 No. 4 323 1,2-Octanediol 5% Topical Liquid
Vol. 20 No. 4 324 Phytonadione 1-mg/mL Oral Solution
Vol. 20 No. 4 325 Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Vol. 20 No. 4 326 Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Vol. 20 No. 4 327 Tretinoin 10-mg Oral Capsules
Vol. 20 No. 4 328 Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Vol. 20 No. 4 333 Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Vol. 20 No. 4 338 Stability of Ampicillin in Normal Saline and Buffered Normal Saline
Vol. 20 No. 4 343 Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Vol. 20 No. 4 347 Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Vol. 20 No. 4 351 Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Vol. 20 No. 5 356 PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Vol. 20 No. 5 359 Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Vol. 20 No. 5 367 Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Vol. 20 No. 5 377 More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!
Vol. 20 No. 5 381 Quality Control Analytical Methods: Method Validation
Vol. 20 No. 5 389 Basics of Compounding: Clinical Pharmaceutics, Part 1
Vol. 20 No. 5 399 Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Vol. 20 No. 5 405 Calculations
Vol. 20 No. 5 406 Clobazam 1-mg/mL Oral Suspension
Vol. 20 No. 5 407 Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Vol. 20 No. 5 408 Inamrinone 5-mg/mL Injection
Vol. 20 No. 5 409 Levetiracetam 50-mg/mL Oral Suspension
Vol. 20 No. 5 410 Naproxen 5% Cream
Vol. 20 No. 5 411 Permethrin 1% Lotion
Vol. 20 No. 5 412 Progesterone 10% Cream
Vol. 20 No. 5 413 Sodium Phosphate Oral Solution
Vol. 20 No. 5 414 Tetracaine Hydrochloride 2% Topical Solution
Vol. 20 No. 5 415 Tromethamine Injection
Vol. 20 No. 5 416 Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Vol. 20 No. 5 421 Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Vol. 20 No. 5 426 Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Vol. 20 No. 5 435 Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light
Vol. 20 No. 5 438 A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Vol. 20 No. 6 444 PreScription: Two Decades of IJPC
Vol. 20 No. 6 447 Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Vol. 20 No. 6 457 U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Vol. 20 No. 6 461 Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Vol. 20 No. 6 469 Why Become Pharmacy Compounding Accreditation Board Accredited?
Vol. 20 No. 6 477 The "Lists": What Do They Mean?
Vol. 20 No. 6 481 Introduction to Quality Control in a Compounding Pharmacy
Vol. 20 No. 6 485 Basics of Compounding: Clinical Pharmaceutics, Part 2
Vol. 20 No. 6 495 Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Vol. 20 No. 6 502 Calculations
Vol. 20 No. 6 504 Alendronate 70-mg/75-mL Drinkable Formulation
Vol. 20 No. 6 505 Bosentan 6.25-mg/mL Oral Suspension
Vol. 20 No. 6 506 Capsaicin 0.025% and Doxepin 3.3% Cream
Vol. 20 No. 6 507 Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Vol. 20 No. 6 508 Erlotinib 10-mg/mL Oral Suspension
Vol. 20 No. 6 509 Flumazenil 0.1-mg/mL Injection
Vol. 20 No. 6 510 Imatinib 40-mg/mL Oral Suspension
Vol. 20 No. 6 511 Lapatinib Ditosylate 50-mg/mL Oral Suspension
Vol. 20 No. 6 512 Melatonin 2-mg/mL Oral Suspension
Vol. 20 No. 6 513 Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Vol. 20 No. 6 514 Stability of Fentanyl Citrate in Polyolefin Bags
Vol. 20 No. 6 517 Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Vol. 20 No. 6 521 Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Vol. 20 No. 6 526 PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution